Influence of sodium lauryl sulfate and Tween 80 on carbamazepine-nicotinamide cocrystal solubility and dissolution behaviour

Pharmaceutics

Volumn 5, Issue 4, 2013, Pages 508-524

  Li, Mingzhong ^a   Qiao, Ning ^a   Wang, Ke ^a  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

Carbamazepine nicotinamide cocrystal; Intrinsic dissolution rate; Raman spectroscopy; Surfactant; UV imaging

Indexed keywords

CARBAMAZEPINE; CARBAMAZEPINE NICOTINAMIDE COCRYSTAL; DODECYL SULFATE SODIUM; NICOTINAMIDE; POLYSORBATE 80; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROMETRY; MICROSCOPY; PHYSICAL CHEMISTRY; RAMAN SPECTROMETRY; ULTRAVIOLET SPECTROSCOPY;

EID: 84885894274     PISSN: None     EISSN: 19994923     Source Type: Journal    
DOI: 10.3390/pharmaceutics5040508     Document Type: Article

References (32)

1. Qiao, N.; Li, M.; Schlindwein, W.; Malek, N.; Davies, A.; Trappitt, G. Pharmaceutical cocrystals: An overview. Int. J. Pharm. 2011, 419, 1-11.
2. Aakeroy, C.B.; Fasulo, M.; Schultheiss, N.; Desper, J.; Moore, C. Structural competition between hydrogen bonds and halogen bonds. J. Am. Chem. Soc. 2007, 129, 13772-13773.
3. Childs, S.L.; Chyall, L.J.; Dunlap, J.T.; Smolenskaya, V.N.; Stahly, B.C.; Stahly, G.P. Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids. J. Am. Chem. Soc. 2004, 126, 13335-13342.
4. Greco, K.; Bogner, R. Solution-mediated phase transformation: Significance during dissolution and implications for bioavailability. J. Pharm. Sci. 2012, 101, 2996-3018.
5. Shiraki, K.; Takata, N.; Takano, R.; Hayashi, Y.; Terada, K. Dissolution improvement and the mechanism of the improvement from cocrystallization of poorly water-soluble compounds. Pharm. Res. 2008, 25, 2581-2592.
6. McNamara, D.; Childs, S.; Giordano, J.; Iarriccio, A.; Cassidy, J.; Shet, M.; Mannion, R.; O'Donnell, E.; Park, A. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. Pharm. Res. 2006, 23, 1888-1897.
7. Basavoju, S.; Bostrom, D.; Velaga, S. Indomethacin-saccharin cocrystal: Design, synthesis and preliminary pharmaceutical characterization. Pharm. Res. 2008, 25, 530-541.
8. Qiao, N.; Wang, K.; Schlindwein, W.; Davies, A.; Li, M. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour. Eur. J. Pharm. Biopharm. 2013, 83, 415-426.
9. Simonelli, A.P.; Mehta, S.C.; Higuchi, W.I. Inhibition of sulfathiazole crystal growth by polyvinylpyrrolidone. J. Pharm. Sci. 1970, 59, 633-638.
10. Gift, A.D.; Luner, P.E.; Luedeman, L.; Taylor, L.S. Influence of polymeric excipients on crystal hydrate formation kinetics in aqueous slurries. J. Pharm. Sci. 2008, 97, 5198-5211.
11. Katzhendler, I.; Azoury, R.; Friedman, M. Crystalline properties of carbamazepine in sustained release hydrophilic matrix tablets based on hydroxypropyl methylcellulose. J. Control. Release 1998, 54, 69-85.
12. Jinno, J.; Oh, D.-M.; Crison, J.R.; Amidon, G.L. Dissolution of ionizable water-insoluble drugs: The combined effect of ph and surfactant. J. Pharm. Sci. 2000, 89, 268-274.
13. Aburub, A.; Risley, D.S.; Mishra, D. A critical evaluation of fasted state simulating gastric fluid (FaSSGF) that contains sodium lauryl sulfate and proposal of a modified recipe. Int. J. Pharm. 2008, 347, 16-22.
14. He, Y.; Yalkowsky, S.H. Solubilization of monovalent weak electrolytes by micellization or complexation. Int. J. Pharm. 2006, 314, 15-20.
15. Seedher, N.; Kanojia, M. Micellar solubilization of some poorly soluble antidiabetic drugs: A technical note. AAPS PharmSciTech 2008, 9, 431-436.
16. Li, P.; Tabibi, S.E.; Yalkowsky, S.H. Combined effect of complexation and ph on solubilization. J. Pharm. Sci. 1998, 87, 1535-1537.
17. Remenar, J.F.; Peterson, M.L.; Stephens, P.W.; Zhang, Z.; Zimenkov, Y.; Hickey, M.B. Celecoxib:Nicotinamide dissociation: Using excipients to capture the cocrystal's potential. Mol. Pharm. 2007, 4, 386-400.
18. Huang, N.; Rodriguez-Hornedo, N. Engineering cocrystal solubility, stability, and phmax by micellar solubilization. J. Pharm. Sci. 2011, 100, 5219-5234.
19. Huang, N.; Rodriguez-Hornedo, N. Engineering cocrystal thermodynamic stability and eutectic points by micellar solubilization and ionization. CrystEngComm 2011, 13, 5409-5422.
20. Huang, N.; Rodriguez-Hornedo, N. Effect of micellar solubilization on cocrystal solubility and stability. Cryst. Growth Des. 2010, 10, 2050-2053.
21. Ostergaard, J.; Meng-Lund, E.; Larsen, S.; Larsen, C.; Petersson, K.; Lenke, J.; Jensen, H. Real-time UV imaging of nicotine release from transdermal patch. Pharm. Res. 2010, 27, 2614-2623.
22. Ostergaard, J.; Ye, F.; Rantanen, J.; Yaghmur, A.; Larsen, S.W.; Larsen, C.; Jensen, H. Monitoring lidocaine single-crystal dissolution by ultraviolet imaging. J. Pharm. Sci. 2011, 100, 3405-3410.
23. Meyer, M.C.; Straughn, A.B.; Jarvi, E.J.; Wood, G.C.; Pelsor, F.R.; Shah, V.P. The bioinequivalence of carbamazepine tablets with a history of clinical failures. Pharm. Res. 1992, 9, 1612-1616.
24. Berry, D.J.; Seaton, C.C.; Clegg, W.; Harrington, R.W.; Coles, S.J.; Horton, P.N.; Hursthouse, M.B.; Storey, R.; Jones, W.; Friscic, T.; et al. Applying hot-stage microscopy to co-crystal screening: A study of nicotinamide with seven active pharmaceutical ingredients. Cryst. Growth Des. 2008, 8, 1697-1712.
25. Good, D.J.; Rodriguez-Hornedo, N. Solubility advantage of pharmaceutical cocrystals. Cryst. Growth Des. 2009, 9, 2252-2264.
26. Good, D.J.; Rodriguez-Hornedo, N. Cocrystal eutectic constants and prediction of solubility behavior. Cryst. Growth Des. 2010, 10, 1028-1032.
27. Bethune, S.J.; Huang, N.; Jayasankar, A.; Rodriguez-Hornedo, N. Understanding and predicting the effect of cocrystal components and pH on cocrystal solubility. Cryst. Growth Des. 2009, 9, 3976-3988.
28. Higuchi, W.I.; Mir, N.A.; Desai, S.J. Dissolution rates of polyphase mixtures. J. Pharm. Sci. 1965, 54, 1405-1410.
29. Grossjohann, C.; Eccles, K.S.; Maguire, A.R.; Lawrence, S.E.; Tajber, L.; Corrigan, O.I.; Healy, A.M. Characterisation, solubility and intrinsic dissolution behaviour of benzamide: Dibenzyl sulfoxide cocrystal. Int. J. Pharm. 2012, 422, 24-32.
30. Sanghvi, R.; Evans, D.; Yalkowsky, S.H. Stacking complexation by nicotinamide: A useful way of enhancing drug solubility. Int. J. Pharm. 2007, 336, 35-41.
31. Chen, L.; Wesley, J.; Bhattachar, S.; Ruiz, B.; Bahash, K.; Babu, S. Dissolution behavior of a poorly water soluble compound in the presence of tween 80. Pharm. Res. 2003, 20, 797-801.
32. Mullin, J.W. Crystallization, 3rd ed.; Butterworth-Heinemann: Oxford, UK, 1993.